2024-26801. Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug User Fee Program  

  • Table 1—Estimated Annual Reporting Burden 1

    Prescription drug user fee activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours
    Sections 735 and 736 of the FD&C Act (PDUFA waivers and exemptions, not including small business waiver requests) 99 1.828 181 17 3,077
    Section 736(d)(1)(C) of the FD&C Act and Form FDA 3971 (small business waivers) 35 1 35 2 70
    Reconsideration Requests 13 1.69 22 24 528
    Appeal Requests 4 1.5 6 12 72
    User Fee Cover Sheet Form FDA 3397 submission with original NDAs and BLAs 132 1.24 164 0.5 (30 minutes) 82
    Total 408 3,829
    1  There are no capital costs or operating and maintenance costs associated with this collection of information.

Document Information

Published:
11/18/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2024-26801
Dates:
Either electronic or written comments on the collection of information must be submitted by January 17, 2025.
Pages:
90705-90708 (4 pages)
Docket Numbers:
Docket No. FDA-2024-N-4467
PDF File:
2024-26801.pdf